Key result
Ischemic heart disease drives ~56% of cardiovascular deaths across cancer types despite rising hypertensive mortality.
Why the study?
The study aimed to evaluate disease-specific cardiovascular causes of mortality and temporal trends by age, sex, and cancer site among cancer patients in the USA between 1999 and 2019.
What are the temporal trends in disease-specific causes of cardiovascular mortality among patients with cancer?
Observational (n=629,308)
What are the temporal trends in disease-specific causes of cardiovascular mortality among patients with cancer?
Highlights the evolving cardiovascular mortality risks in cancer patients, emphasizing the need for targeted cardiovascular risk factor modification, particularly for hypertension.
May warrant closer hypertension monitoring in cancer survivors; leaves open causal drivers of shifting CV mortality patterns.
AIMS: We report disease-specific cardiovascular causes of mortality among cancer patients in the USA between 1999 and 2019, considering temporal trends by age, sex, and cancer site. METHODS AND RESULTS: We used the Multiple Cause of Death database, accessed through the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research resource. We included 629 308 decedents with cardiovascular disease (CVD) recorded as the primary cause of death and active malignancy listed as a contributing cause of death. We created disease-specific CVD categories and grouped cancers by site. We calculated the proportion of CVD deaths attributed to each disease category stratified by sex, age, and cancer site. We also examined disease-specific temporal trends by cancer site. Ischaemic heart disease (IHD) was the most common cardiovascular cause of death across all cancer types (55.6%), being more common in men (59.8%), older ages, and in those with lung (67.8%) and prostate (58.3%) cancers. Cerebrovascular disease (12.9%) and hypertensive diseases (7.6%) were other common causes of death. The proportion of deaths due to heart failure was greatest in haematological (7.7%) and breast (6.3%) cancers. There was a decreasing temporal trend in the proportion of cardiovascular deaths attributed to IHD across all cancer types. The proportion of deaths due to hypertensive diseases showed the greatest percentage increase, with the largest change in breast cancer patients (+191.1%). CONCLUSION: We demonstrate differential cardiovascular mortality risk by cancer site and demographics, providing insight into the evolving healthcare needs of this growing high-cardiovascular risk population.
No takes yet. Share an insight, caveat, or question.
Raisi‐Estabragh et al. (2022) conducted an observational in Cancer with cardiovascular mortality (n=629,308). Cancer (lung, gastrointestinal, prostate, breast, haematological) was evaluated on Proportion of cardiovascular deaths attributed to specific cardiovascular diseases. Ischemic heart disease was the most common cardiovascular cause of death across all cancer types (55.6%), though its proportion declined from 1999 to 2019, while hypertensive disease deaths increased by 174.5%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: